Alice H Berger

Alice H Berger

UNVERIFIED PROFILE

Are you Alice H Berger?   Register this Author

Register author
Alice H Berger

Alice H Berger

Publications by authors named "Alice H Berger"

Are you Alice H Berger?   Register this Author

20Publications

682Reads

39Profile Views

Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis.

J Clin Invest 2019 01 26;129(1):215-222. Epub 2018 Nov 26.

Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI99699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307955PMC
January 2019

Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma.

Cancer Res 2017 08 18;77(16):4498-4505. Epub 2017 May 18.

Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-1944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004099PMC
August 2017

The role of C1q in recognition of apoptotic epithelial cells and inflammatory cytokine production by phagocytes during Helicobacter pylori infection.

J Inflamm (Lond) 2015 8;12:51. Epub 2015 Sep 8.

Department of Pathology, University of California, La Jolla, San Diego, CA USA ; Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12950-015-0098-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563842PMC
September 2015

DOK2 inhibits EGFR-mutated lung adenocarcinoma.

PLoS One 2013 8;8(11):e79526. Epub 2013 Nov 8.

Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0079526PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821857PMC
September 2014

Dosage and tumour suppression.

J Pathol 2012 Jun;227(2):e1; author reply e2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4035DOI Listing
June 2012

A continuum model for tumour suppression.

Nature 2011 Aug 10;476(7359):163-9. Epub 2011 Aug 10.

Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature10275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206311PMC
August 2011

Haplo-insufficiency: a driving force in cancer.

J Pathol 2011 Jan 29;223(2):137-46. Epub 2010 Oct 29.

Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2800DOI Listing
January 2011

Identification of DOK genes as lung tumor suppressors.

Nat Genet 2010 Mar 7;42(3):216-23. Epub 2010 Feb 7.

Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956443PMC
March 2010